When was Pirouette Pharma founded?

Pirouette Pharma was founded in 2021 and raised its 1st funding round within a year of its incorporation.

Where is Pirouette Pharma located?

Pirouette Pharma is headquartered in Portsmouth, United States.

Who is the current CEO of Pirouette Pharma?

Conor R Cullinane and Conor Cullinane Phd s of Pirouette Pharma. Conor R Cullinane has also founded 1 company.

How many employees does Pirouette Pharma have?

As of Sep 30, 2026, the latest employee count at Pirouette Pharma is 32.

Is Pirouette Pharma a funded company?

Pirouette Pharma is a funded company, having raised a total of $3.43M across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Oct 2021.

When was the latest funding round of Pirouette Pharma?

Pirouette Pharma's latest funding was a $***** Seed round on Mar 10, 2026, with participation from 0 investor. Its primary sector is Drug Delivery. In United States, the Drug Delivery sector has seen $257M in funding in 2026 to date.

Where does Pirouette Pharma rank among its competitors?

Pirouette Pharma ranks 3rd amongst 35 active competitors, of which 7 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Pirouette Pharma, which secured $1.08M in Mar, 2026.

Who are the top competitors of Pirouette Pharma?

Pirouette Pharma's top competitors include Xeris Pharmaceuticals, Crossject and SHL. Among them, Pirouette Pharma secured the most recent funding round in March, 2026.

Pirouette Pharma - 2026 Company Profile, Team, Funding & Competitors

Pirouette Pharma is a seed company based in Portsmouth (United States), founded in 2021 by Matthew J Kane, Elijah M Kapas, Conor R Cullinane and Conor Cullinane Phd. It operates as a Developer of auto-injector technology for injectable medicines and partner programs. Pirouette Pharma has raised $3.43M in funding. The company has 35 active competitors, including 7 funded and 3 that have exited. Its top competitors include companies like Xeris Pharmaceuticals, Crossject and SHL.

Company Details

Developer of auto-injector technology for injectable medicines and partner programs. The company’s platform is designed for subcutaneous or intramuscular dosing. It focuses on creating devices that improve patient comfort and adherence to prescribed schedules. The technology aims to reduce needle visibility and sensation during self-administration of medications.

Website: www.pirouettepharma.com/
Social
Email ID: *****@pirouettepharma.com
Phone Number: +1 **********

Key Metrics

Founded Year

2021

Location

Portsmouth, United States

Stage

Seed

Total Funding

$3.43M in 4 rounds

Latest Funding Round

Seed, Mar 10, 2026, $*****

Investors

Founders & 2 more

Ranked

3^rd among 35 active competitors

Employee Count

32 as on Sep 30, 2026

Similar Companies

Xeris Pharmaceuticals & 34 more

View Pirouette Pharma's full profile

Pirouette Pharma has raised a total funding of $3.43M over 4 rounds. Its first funding round was on Oct 2021. Pirouette Pharma has 3 institutional investors.

Here is the list of recent funding rounds of Pirouette Pharma:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 10, 2026	6026324	Seed	6109367	3201988	3156641	8584656
Mar 28, 2025	1322182	Seed	9719640	4408373	5459427	7842675
Aug 01, 2023	3575286	Grant (prize money)	2686873	7355159	5343942	HHS

Access funding benchmarks and valuations. Sign up today!

View details of Pirouette Pharma's funding rounds and investors

The founders of Pirouette Pharma are Matthew J Kane, Elijah M Kapas, Conor R Cullinane and Conor Cullinane Phd. Conor Cullinane Phd and Conor R Cullinane are the CEOs of Pirouette Pharma.

Here are the details of Pirouette Pharma's key team members:

Matthew J Kane: Co-Founder of Pirouette Pharma.
Contact Info: 1 email address
Elijah M Kapas: Co-Founder & Chief Technology Officer of Pirouette Pharma.
Contact Info: 1 email address
Conor R Cullinane: Co‑Founder, Chairman, CEO of Pirouette Pharma.
Contact Info: 1 email address
Conor Cullinane Phd: Co-Founder & CEO of Pirouette Pharma.
Contact Info: 2 email addresses

View details of Pirouette Pharma's Founder profiles and Board Members

Pirouette Pharma's employee count trend

Pirouette Pharma has 32 employees as of Sep 26. Here is Pirouette Pharma's employee count trend over the years:

Employee count trend for Pirouette Pharma

Uncover Pirouette Pharma's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Pirouette Pharma include Xeris Pharmaceuticals, Crossject and SHL. Here is the list of Top 10 competitors of Pirouette Pharma, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Xeris Pharmaceuticals 2005, Chicago (United States), Public	Developer of liquid-stable injectables for the delivery of drugs	$155M	Redmile Group, Central Texas Angel Network ... & 19 others	62/100
2nd	Crossject 2001, Dijon (France), Public	Needle-free self-injectable drugs	$40.3M	Rothschild & Co, GSK & 5 others	62/100
3rd	Pirouette Pharma 2021, Portsmouth (United States), Seed	Developer of auto-injector technology for injectable medicines and partner programs	$3.43M	Founders, HHS & 1 others	49/100
4th	SHL 1989, Zug (Switzerland), Funding Raised	Developer and manufacturer of autoinjectors and drug delivery system solutions	-	EQT, Athos Capital & 1 others	45/100
5th	Windgap Medical 2011, Boston (United States), Series B	Provider of drug delivery autoinjector for the treatment of anaphylaxis	$76.7M	Taiwania Capital, SKK & 12 others	42/100
6th	Eveon 2009, Montbonnot Saint Martin (France), Seed	Manufacture of connected medical devices focused on the preparation and administration of therapeutic treatment	$4.05M	MEDEVICE, Credit Agricole Alpes Developpement ... & 1 others	40/100
7th	MIT 1978, Montreal (Canada), Public	Provider of needleless injectors for various medical applications	-	-	37/100
8th	Qlibrium 2014, Woburn (United States), Funding Raised	Provider of on‑body drug delivery systems	-	JLABS, MassChallenge & 1 others	36/100
9th	Cellular Vehicles 2021, San Mateo (United States), Funding Raised	Developer of process automation tools for cell-based therapy manufacturing	-	Boost VC, HHS	35/100
10th	Asan Therapeutics Boston (United States), Unfunded	Developer of drug delivery technology to treat cancer patients	-	-	32/100